CEO of Tylenol Manufacturer Addresses Autism Concerns in Meeting with RFK Jr.
September 12, 2025 - 20:35
In a recent private meeting, the interim CEO and director of Kenvue, the company behind the popular pain reliever Tylenol, engaged in discussions with U.S. Health and Human Services Secretary Robert F. Kennedy Jr. The meeting aimed to address concerns regarding the potential association between the medication and autism. The CEO emphasized that scientific research has not established any clear link between the use of Tylenol and the development of autism spectrum disorders.
The dialogue comes amidst rising scrutiny and ongoing debates surrounding the safety of various medications during pregnancy and early childhood. The CEO's efforts appear to be focused on preventing the inclusion of Tylenol in a forthcoming report that could suggest a connection to autism, a point of contention that has garnered significant public interest and concern.
Both parties acknowledged the importance of continuing to review and analyze existing research to ensure public safety while addressing the anxieties of parents and caregivers.
MORE NEWS
February 24, 2026 - 18:27
READY, SET, IMPLEMENT! Lifelines in Crisis: Prioritizing Women’s, Children’s, and Adolescents’ Health in Humanitarian and Conflict-affected SettingsIn a world increasingly defined by conflict, climate disasters, and displacement, a state of permanent crisis is threatening the health and rights of the most vulnerable. Over half of all maternal...
February 24, 2026 - 12:34
NO.olistudy,health.031526_2937 MJ.JPGA new, wireless sensor system is being introduced with the goal of enhancing safety and comfort for mothers during labor and delivery. The device, known as the Oli sensor, represents a significant...
February 23, 2026 - 14:37
Democrats decry meager medical care for detainees in funding fightA stark human cost is emerging within the nation`s immigration detention system, as advocates and lawmakers highlight dangerously inadequate medical care for detainees, trapped in a broader...
February 22, 2026 - 20:59
Study identifies long-term health risks in testicular cancer survivors treated with contemporary chemotherapyA landmark study has revealed that men who received modern chemotherapy regimens for testicular cancer face significantly elevated risks for a range of serious long-term health conditions, even...